News

With construction of third production line finished, biotech company says it can manufacture two billion doses annually

New benchmark is expected to be met by end of 2021, BioNTech says

Will purchase Hemmo Pharmaceuticals, one of India's largest producers of synthetic peptides

SK Capital renames CDMO business Woodstock Sterile Solutions

The latest people news happenings over the past month

Acquisition further develops KD Pharma’s CDMO capabilities

Company markets unique approach to managing pharma supply chains

The big pharma will help fill and finish up to 60 million doses of Novavax' coronavirus candidate

Deal allows for more transport options, temperature control

Makes up to 400 million doses of J&J's Covid vaccine available to the African Union through 2022

Open Credentialing Initiative (OCI) brings together multiple DSCSA software vendors

Opens up additional European sites for dose manufacturing

Report: HHS stops shipping of the solo therapy due to variant impact

Its new platform simplifies the process of making digital connections, including enabling the efficient exchange of critical information, the association says

Biomedical freezer maker to combine with supplier of cell and gene therapy tools

Aktana releases AI engagement tool focused on the needs of growing biopharma companies

Program is part of association's broader efforts to illustrate the impact of distributors on US healthcare ecosystem

Expansion in response to growing industry demand for products to transport temperature-sensitive cell and gene therapies

Cell culture facility expected to be largest in North America, according to the manufacturer

2020 was a difficult year for many patients, but new data may signal a brighter future ahead

Location will be purchased by WuXi Biologics, according to report

New refrigerators include -80°C (-112°F) service

The commission is launching a broad review of drug-company mergers to explore how such deals can potentially harm industry competition

Production will occur at IDT’s Germany facilities for a three-month span

Agreement focused on enhancing insights into the location and condition of temperature-sensitive drugs and vaccines, including ones for Covid-19

Trial results could answer questions regarding reports of serious blood clots

Deal bolsters ANI’s generics and CDMO portfolio